We really need to see some detail in this 4C - I know the line has been JV partner has gagged us but we own half this JV also! Competitors can see the traction Zoleo is getting, we have told the market 100,000 units have been ordered PLUS you announce 50,000 Plus subscribers and it generates buzz and people adopt quicker on basis of it is validating the product and they view the growth as an endorsement so what harm can it really do. I do not see the reason why RoadPost wants to keep it all hush still.
Also feel it would not hurt to put forward some sort of half year EBITDA or 2022 full year EBITDA guidance, be conservative and just say $1.5 to 2.0 million etc which maybe is a FY guide? Whatever it is but they should be able to get a red on it now with confirmed Go! sales, and other Zoleo numbers tracking along. Chances are there would only be upside as expenses should be fairly known and committed sales same.
BCC Price at posting:
27.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)